
Overview
Fortis Pharmaceuticals is a dynamic Polish pharmaceutical company that develops high-quality health products. It offers a range of dietary supplements such as Tribiolac, Gardipect, and Solvit D3, as well as medications including Ibufast Forte and Diclogel. The company focuses on improving patient health and comfort through its diverse product line.
Financials
Revenue history (in k)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 80 days late).
- 202514/07/2026
- 202410/07/2025
- 202303/07/2024
- 202230/06/2023
- 202103/10/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Painkillers
- Cold medicines
- Eye care products
- Head lice treatments
- Medical devices
- Dietary supplements
Websites
- fortispharmaceuticals.plFortis - strona głównaGoogle Tag ManagerApache
Trademarks
The company holds 26 active trademarks registered with the Polish Patent Office. 1 application is pending. 2 marks have expired or were not registered. The first mark was filed in 2012.
| Mark | Protected until | |
|---|---|---|
| WITAMINA D3 FORTIS (word) | Nov 8, 2034 | |
| tadalafil fortis (word) | May 24, 2032 | |
| DEVIR (word) | May 24, 2032 | |
| Gastroprazol (word) | May 24, 2032 | |
| NEOCLIN (word) | Dec 14, 2031 |
Job offers
The company has its own careers page: fortispharmaceuticals.pl/pl.kariera_08c.html.
Authorized Representatives
Manner of representation
The right and obligation to represent and conduct the affairs of the transformed company shall be vested in the management board of the transformed company, acting in accordance with the rules of representation specified by the Commercial Companies Code and the articles of association of the company operating under the business name FORTIS PHARMACEUTICALS spółka z ograniczoną odpowiedzialnością with its registered office in Katowice. The management board consists of 1 to 3 members appointed by a resolution of the meeting of partners. The management board is appointed for an indefinite period; however, the partners’ resolution appointing the management board may provide otherwise. Szymon Kamiński shall be President of the Management Board of the transformed company, and Dominik Kołodziej shall be Vice-President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Szymon Dawid Kamiński age 46 | 100 | $2,701.24 | 50% |
Dominik Marcin Kołodziej age 45 | 100 | $2,701.24 | 50% |
Bank accounts
Registered as a VAT taxpayer on 2012-07-18.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
26 public aid cases recorded, with a total value of $309,401.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 26, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $21,246$21,246 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 17, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,573$1,573 | Marszałek Województwa Śląskiego | |
| Mar 26, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $24,756$24,756 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aristo Pharma sp. z o.o. | $22,775,627.72 | aristo-pharma.pl | ||
| Orifarm Healthcare sp. z o.o. | $11,159,864.42 | orifarmhealth.pl | ||
| Biofaktor sp. z o.o. | $10,761,755.73 | biofaktor.pl | ||
| Fatro Polska sp. z o.o. | $7,352,000.52 | fatro-polska.com.pl | ||
| Biovena Health sp. z o.o. | $6,016,230.67 | biovenahealth.com | ||
| Ethifarm sp. z o.o. + limited partnership | $5,691,422.61 | ethifarm.pl | ||
| Adpharma sp. z o.o. | $5,595,917.60 | adamed.com | ||
| Vitama S.A. | $4,287,087.38 | vitama.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemiczne sp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Plus Solinea Pharma sp. z o.o. | $1,005,025.44 | solinea.pl |
FAQ
Last updated: 2026-07-17
